COVID-19 Vaccination in Kidney Transplant Recipients: An Ounce Pre-Transplant is Worth a Pound Post-Transplant.
作者信息
Chandran Sindhu, Stock Peter G
机构信息
Department of Medicine, University of California, San Francisco.
Department of Surgery, University of California, San Francisco.
出版信息
J Am Soc Nephrol. 2021 Dec 1;32(12):2977-2978. doi: 10.1681/ASN.2021101347.
Abstract
摘要
相似文献
1
COVID-19 Vaccination in Kidney Transplant Recipients: An Ounce Pre-Transplant is Worth a Pound Post-Transplant.肾移植受者的新冠病毒疫苗接种：移植前预防一分，胜过移植后治疗十分。
J Am Soc Nephrol. 2021 Dec 1;32(12):2977-2978. doi: 10.1681/ASN.2021101347.
2
Renal Complications in Kidney Transplant Recipients After Whole-virus Inactivated COVID-19 Vaccination.全病毒灭活新冠疫苗接种后肾移植受者的肾脏并发症
Transplantation. 2022 Nov 1;106(11):e510-e511. doi: 10.1097/TP.0000000000004330. Epub 2022 Sep 19.
3
COVID-19 vaccination in kidney transplant recipients.肾移植受者的 COVID-19 疫苗接种。
Nat Rev Nephrol. 2021 Dec;17(12):785-787. doi: 10.1038/s41581-021-00491-7.
4
SARS-CoV-2 Vaccination in Kidney Transplant Recipients: Should We Consider Intradermal Vaccination?肾移植受者的新型冠状病毒 2 型疫苗接种：我们是否应考虑皮内接种？
J Am Soc Nephrol. 2022 Apr;33(4):869-870. doi: 10.1681/ASN.2021121566. Epub 2022 Feb 14.
5
Humoral Response After 5 Successive Doses of COVID-19 Vaccine in Kidney Transplant Patients: Comment.肾移植患者连续5剂新冠疫苗后的体液反应：评论
Transplantation. 2023 Nov 1;107(11):e319. doi: 10.1097/TP.0000000000004756. Epub 2023 Oct 21.
6
Authors' Reply: SARS-CoV-2 Vaccination in Kidney Transplant Recipients: Should We Consider Intradermal Vaccination?作者回复：肾移植受者中的新型冠状病毒2型疫苗接种：我们是否应考虑皮内接种？
J Am Soc Nephrol. 2022 Apr;33(4):870-871. doi: 10.1681/ASN.2022010033. Epub 2022 Feb 14.
7
Humoral Response After Five Successive Doses of SARS-CoV-2 mRNA Vaccine in Kidney Transplant Patients.肾移植患者连续五剂接种SARS-CoV-2 mRNA疫苗后的体液免疫反应
Transplantation. 2023 Jul 1;107(7):e188-e189. doi: 10.1097/TP.0000000000004628. Epub 2023 May 12.
8
Humoral Response After SARS-CoV-2 Vaccination in Kidney Transplant Recipients: Role of Immunosuppression Therapy.肾移植受者接种 SARS-CoV-2 疫苗后的体液免疫反应：免疫抑制治疗的作用。
Transplant Proc. 2022 Nov;54(9):2454-2456. doi: 10.1016/j.transproceed.2022.09.019. Epub 2022 Oct 3.
9
Humoral Response after SARS-CoV-2 mRNA Vaccination in a Cohort of Hemodialysis Patients and Kidney Transplant Recipients.血液透析患者和肾移植受者队列中 SARS-CoV-2 mRNA 疫苗接种后的体液反应。
J Am Soc Nephrol. 2021 Sep;32(9):2153-2158. doi: 10.1681/ASN.2021040490. Epub 2021 Jun 16.
10
Delayed kinetics of SARS-CoV-2 IgG antibody production in kidney transplant recipients following the third dose of COVID-19 vaccination.肾移植受者在接种第三剂新冠疫苗后，新冠病毒2型免疫球蛋白G抗体产生的动力学延迟
Clin Exp Nephrol. 2023 Jan;27(1):98-99. doi: 10.1007/s10157-022-02261-6. Epub 2022 Aug 5.
引用本文的文献
1
Effects of anti-SARS-CoV-2 vaccination in living kidney transplant recipients prior to transplantation.抗SARS-CoV-2疫苗接种对活体肾移植受者移植前的影响。
Clin Exp Nephrol. 2024 Dec;28(12):1332-1333. doi: 10.1007/s10157-024-02535-1. Epub 2024 Jul 6.
2
Differences in Responses of Immunosuppressed Kidney Transplant Patients to Moderna mRNA-1273 versus Pfizer-BioNTech.免疫抑制的肾移植患者对Moderna mRNA-1273与辉瑞-生物科技公司疫苗反应的差异
Vaccines (Basel). 2024 Jan 17;12(1):91. doi: 10.3390/vaccines12010091.
3
Literature review on COVID-19 vaccine efficacy in the immunocompromised population, and possible implications to future vaccination in kidney transplant patients.关于新冠病毒疫苗在免疫功能低下人群中的有效性以及对肾移植患者未来疫苗接种可能影响的文献综述。
Front Med (Lausanne). 2023 Feb 2;10:1103699. doi: 10.3389/fmed.2023.1103699. eCollection 2023.
4
Management of COVID-19 in Kidney Transplant Recipients: A Single-Center Case Series.肾移植受者新型冠状病毒肺炎的管理：单中心病例系列
Int J Nephrol. 2022 Aug 18;2022:9636624. doi: 10.1155/2022/9636624. eCollection 2022.
本文引用的文献
1
B and T Cell Responses after a Third Dose of SARS-CoV-2 Vaccine in Kidney Transplant Recipients.肾移植受者接种第三剂 SARS-CoV-2 疫苗后的 B 和 T 细胞反应。
J Am Soc Nephrol. 2021 Dec 1;32(12):3027-3033. doi: 10.1681/ASN.2021070966.
2
Temporary hold of mycophenolate augments humoral response to SARS-CoV-2 vaccination in patients with rheumatic and musculoskeletal diseases: a case series.霉酚酸临时停药增强风湿性和肌肉骨骼疾病患者对SARS-CoV-2疫苗的体液免疫反应：病例系列
Ann Rheum Dis. 2022 Feb;81(2):293-295. doi: 10.1136/annrheumdis-2021-221252. Epub 2021 Sep 23.
3
Intensity of mycophenolate mofetil treatment is associated with an impaired immune response to SARS-CoV-2 vaccination in kidney transplant recipients.霉酚酸酯治疗强度与肾移植受者对 SARS-CoV-2 疫苗接种的免疫应答受损有关。
Am J Transplant. 2022 Feb;22(2):634-639. doi: 10.1111/ajt.16851. Epub 2021 Nov 1.
4
A third vaccine dose substantially improves humoral and cellular SARS-CoV-2 immunity in renal transplant recipients with primary humoral nonresponse.第三剂疫苗可显著提高原发性体液无反应的肾移植受者的体液和细胞新冠病毒免疫力。
Kidney Int. 2021 Nov;100(5):1135-1136. doi: 10.1016/j.kint.2021.09.001. Epub 2021 Sep 9.
5
Cellular immunity predominates over humoral immunity after homologous and heterologous mRNA and vector-based COVID-19 vaccine regimens in solid organ transplant recipients.在实体器官移植受者中，同源和异源mRNA及载体型新冠疫苗接种方案后，细胞免疫比体液免疫占优势。
Am J Transplant. 2021 Dec;21(12):3990-4002. doi: 10.1111/ajt.16818. Epub 2021 Sep 6.
6
Randomized Trial of a Third Dose of mRNA-1273 Vaccine in Transplant Recipients.移植受者中第三剂mRNA-1273疫苗的随机试验。
N Engl J Med. 2021 Sep 23;385(13):1244-1246. doi: 10.1056/NEJMc2111462. Epub 2021 Aug 11.
7
SARS-CoV-2 Antibody Responses in Infection-Naive or Previously Infected Individuals After 1 and 2 Doses of the BNT162b2 Vaccine.感染前或既往感染者接种 1 剂和 2 剂 BNT162b2 疫苗后的 SARS-CoV-2 抗体反应。
JAMA Netw Open. 2021 Aug 2;4(8):e2119741. doi: 10.1001/jamanetworkopen.2021.19741.
8
Strong antibody response after a first dose of a SARS-CoV-2 mRNA-based vaccine in kidney transplant recipients with a previous history of COVID-19.有新冠病毒疾病既往史的肾移植受者在接种第一剂基于信使核糖核酸的新冠病毒疫苗后产生强烈抗体反应。
Am J Transplant. 2021 Nov;21(11):3808-3810. doi: 10.1111/ajt.16764. Epub 2021 Jul 23.
9
Impaired humoral immunity to SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients and dialysis patients.肾移植受者和透析患者对 SARS-CoV-2 BNT162b2 疫苗的体液免疫受损。
Sci Immunol. 2021 Jun 15;6(60). doi: 10.1126/sciimmunol.abj1031.
10
Impaired humoral and cellular immunity after SARS-CoV-2 BNT162b2 (tozinameran) prime-boost vaccination in kidney transplant recipients.肾移植受者中 SARS-CoV-2 BNT162b2（tozinameran）疫苗加强接种后体液和细胞免疫受损。
J Clin Invest. 2021 Jul 15;131(14). doi: 10.1172/JCI150175.
Zotero 插件